- Home
- ARL vs TIL Comparison
ARL vs TIL Comparison
Compare ARL & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- TIL
- Stock Information
- Founded
- ARL 1999
- TIL 2018
- Country
- ARL United States
- TIL United States
- Employees
- ARL N/A
- TIL N/A
- Industry
- ARL Building operators
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- TIL Health Care
- Exchange
- ARL Nasdaq
- TIL Nasdaq
- Market Cap
- ARL 187.2M
- TIL 171.7M
- IPO Year
- ARL N/A
- TIL 2021
- Fundamental
- Price
- ARL $13.35
- TIL $14.63
- Analyst Decision
- ARL
- TIL Buy
- Analyst Count
- ARL 0
- TIL 5
- Target Price
- ARL N/A
- TIL $114.00
- AVG Volume (30 Days)
- ARL 5.0K
- TIL 179.5K
- Earning Date
- ARL 05-08-2025
- TIL 05-13-2025
- Dividend Yield
- ARL N/A
- TIL N/A
- EPS Growth
- ARL N/A
- TIL N/A
- EPS
- ARL N/A
- TIL N/A
- Revenue
- ARL $48,234,000.00
- TIL N/A
- Revenue This Year
- ARL N/A
- TIL N/A
- Revenue Next Year
- ARL N/A
- TIL N/A
- P/E Ratio
- ARL N/A
- TIL N/A
- Revenue Growth
- ARL N/A
- TIL N/A
- 52 Week Low
- ARL $9.43
- TIL $9.62
- 52 Week High
- ARL $22.77
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ARL 60.02
- TIL 50.17
- Support Level
- ARL $13.00
- TIL $12.60
- Resistance Level
- ARL $13.82
- TIL $14.01
- Average True Range (ATR)
- ARL 0.67
- TIL 1.31
- MACD
- ARL 0.13
- TIL 0.27
- Stochastic Oscillator
- ARL 81.18
- TIL 89.66
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.